Hosted on MSN
Terumo completes $1.5bn acquisition of OrganOx
The technology is approved in Australia, Canada, Europe, and the US, and has been used in more than 6,000 liver transplants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback